About
Technology
Issues
FAQ
Links
Official Page
Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.